Position in BCAB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,114
-$25,190 QoQ
Shares Held
56,614
-6.3% QoQ
Ownership
3.40%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026XTX Topco Ltd holds $412,987,661 across 381 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
30,522 | $19,031,687 | |
| 2 | ASND |
Ascendis Pharma A/S
|
43,289 | $11,546,042 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
116,611 | $8,685,187 | |
| 4 | MRNA |
Moderna, Inc.
|
123,281 | $8,633,368 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
30,496 | $7,348,621 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
61,501 | $7,052,319 | |
| 7 | CYTK |
Cytokinetics Inc
|
80,743 | $6,878,496 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
81,923 | $6,682,459 |
All Filings in BCAB
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,114 | 56,614 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $34,304 | 60,395 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $13,333 | 19,380 | Shares | Defined | 2025-11-14 | |
| 2024-09-30 | $272,741 | 154,967 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $198,078 | 144,583 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $565,422 | 164,367 | Shares | Defined | 2024-05-13 | |
| 2023-09-30 | $62,884 | 36,991 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $331,536 | 110,512 | Shares | Defined | 2023-08-14 | |
| 2022-06-30 | $106,145 | 37,244 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $90,700 | 18,140 | Shares | Defined | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||